BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1825532)

  • 1. Inhibition of de novo synthesis and message expression of prostaglandin H synthase by salicylates.
    Sanduja R; Loose-Mitchell D; Wu KK
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():149-52. PubMed ID: 1825532
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.
    Xu XM; Sansores-Garcia L; Chen XM; Matijevic-Aleksic N; Du M; Wu KK
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5292-7. PubMed ID: 10220459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of de novo synthesis of prostaglandin G/H synthase in endothelial cells.
    Wu KK; Lo SS; Papp AC; Vijjeswarapu HN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():237-41. PubMed ID: 2526475
    [No Abstract]   [Full Text] [Related]  

  • 5. The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1beta at a translational step, but not at a transcriptional step, in hepatocytes.
    Sakitani K; Kitade H; Inoue K; Kamiyama Y; Nishizawa M; Okumura T; Ito S
    Hepatology; 1997 Feb; 25(2):416-20. PubMed ID: 9021956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
    Mitchell JA; Akarasereenont P; Thiemermann C; Flower RJ; Vane JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11693-7. PubMed ID: 8265610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
    Wu KK
    Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts.
    Mifflin RC; Saada JI; Di Mari JF; Valentich JD; Adegboyega PA; Powell DW
    Mol Pharmacol; 2004 Feb; 65(2):470-8. PubMed ID: 14742690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells.
    Wu KK; Sanduja R; Tsai AL; Ferhanoglu B; Loose-Mitchell DS
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2384-7. PubMed ID: 1900943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
    Giuliano F; Mitchell JA; Warner TD
    J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
    Hinz B; Kraus V; Pahl A; Brune K
    Biochem Biophys Res Commun; 2000 Jul; 274(1):197-202. PubMed ID: 10903918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin.
    Bitko V; Velazquez A; Yang L; Yang YC; Barik S
    Virology; 1997 Jun; 232(2):369-78. PubMed ID: 9191851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
    Iñiguez MA; Punzón C; Fresno M
    J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli.
    Negrotto S; Malaver E; Alvarez ME; Pacienza N; D'Atri LP; Pozner RG; Gómez RM; Schattner M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):972-9. PubMed ID: 16936242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes.
    Knott I; Dieu M; Burton M; Houbion A; Remacle J; Raes M
    J Rheumatol; 1994 Mar; 21(3):462-6. PubMed ID: 8006889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oligomer targeted against protein kinase C alpha prevents interleukin-1 alpha induction of cyclooxygenase expression in human endothelial cells.
    Maier JA; Ragnotti G
    Exp Cell Res; 1993 Mar; 205(1):52-8. PubMed ID: 8453997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression.
    Shtivelband MI; Juneja HS; Lee S; Wu KK
    J Thromb Haemost; 2003 Oct; 1(10):2225-33. PubMed ID: 14521608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
    Seibert K; Masferrer J; Zhang Y; Leahy K; Hauser S; Gierse J; Koboldt C; Anderson G; Bremer M; Gregory S
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():125-7. PubMed ID: 7794421
    [No Abstract]   [Full Text] [Related]  

  • 19. Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells.
    Gerli R; Paolucci C; Gresele P; Bistoni O; Fiorucci S; Muscat C; Belia S; Bertotto A; Costantini V
    Blood; 1998 Oct; 92(7):2389-98. PubMed ID: 9746779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms.
    Hulkower KI; Otis ER; Li J; Ennis BW; Cugier DJ; Bell RL; Carter GW; Glaser KB
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1065-74. PubMed ID: 9023325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.